Anondita Medi. moves to reshape its capital structure

Only the total issue size—and the linked issue-share count and GCP allocation—reverts to the original Letter of Offer. The issue price and entitlement ratio remain operative, rather than being nullified.

Corrigendum terms that remain binding

• Announcement No. 2 remains fully effective: the arrangements for disposal of odd lots continue to apply. Rights Entitlements are to be traded and allotted in lots of 10 and multiples thereof. ^[1]
• The corrected Announcement No. 2 continues to recognize a theoretical entitlement of 9,58,166 shares under the 97:1,831 ratio, but clarifies that the company’s structured issue comprises only 9,58,000 shares at Rs 950 per share, aggregating to Rs 9,101.00 Lakhs. ^[1]
• All other paragraphs of Announcement No. 2 remain unchanged, while Announcement No. 1—covering the revised issue size, share count and GCP allocation—is withdrawn with immediate effect. ^[2]

Practical reading: the Corrigendum’s increase in issue size and share count has no continuing effect. Its odd-lot mechanics do continue, while the Rs 950 price and 97:1,831 entitlement ratio remain the operative issue terms.

The partial nullification changes the Rights Issue terms, but the filing does not announce any change to the previously communicated Record Date or subscription period. Announcement No. 1 was withdrawn with immediate effect, restoring the original structure: 9,58,000 Rights Equity Shares, issue size of Rs 9,101.00 Lakhs, and Rs 979.98 Lakhs for general corporate purposes. ^[1] Announcement No. 2, concerning odd-lot disposal arrangements, remains effective. ^[1]

• Record Date: The September 8 filing does not revise, cancel, or reschedule the previously announced Record Date. Accordingly, the earlier Record Date remains the operative date unless the company subsequently issues a separate exchange notice.
• Subscription timeline: The filing does not state that the opening date, closing date, or any other step in the Rights Issue timetable has changed. The partial nullification therefore appears to affect the issue size and allocation—not the subscription timetable.
• Revised schedule of events: No separately revised schedule of events is identified in the cited filing. The company has filed the partial-nullification intimation with NSE, but that document only restores the original issue terms and corrects the related wording; it does not provide a replacement timetable. ^{[2] [1]}

A third-party rights-issue listing showed dates of September 2, September 9, and September 22 for Anondita Medicare, but the cited listing does not identify the precise event corresponding to each date and is not a substitute for an exchange-filed revised schedule. ^[3] Therefore, the practical position is: original dates appear unaffected on the evidence available, but investors should rely on a subsequent company or exchange notice if Anondita formally changes the Record Date or subscription window.

No. The partial nullification reverses the capital-structure changes introduced by Announcement No. 1 of the Corrigendum; it does not leave the issue on the enlarged terms.

• Issue size: The original Letter of Offer terms remain operative: 9,58,000 Rights Equity Shares, aggregating to Rs 9,101.00 Lakhs, or Rs 91.01 Crores, at an issue price of Rs 950 per share. ^{[1] [1]}
• General Corporate Purposes: The allocation reverts to the original Rs 979.98 Lakhs; it is not revised under the nullified Announcement No. 1. ^[1]
• What remains changed: Announcement No. 2, concerning the disposal of odd lots and trading/allotment of Rights Entitlements in lots of 10, remains in force. Its reference to the theoretical entitlement of 9,58,166 shares and Rs 9,102.58 Lakhs was consequentially corrected to the actual issue structure of 9,58,000 shares and Rs 9,101.00 Lakhs. ^{[1] [1]}

Exchange approval status: The filing is an intimation to the NSE requesting that the corrected position be taken on record; it does not report a fresh or revised “in-principle” approval for the modified terms. A copy of an NSE in-principle approval letter had previously been disclosed, but the latest filing does not state that the exchanges have separately re-approved the post-nullification terms. ^[4] Accordingly, the documented position is that the company has restored the original Letter of Offer terms and notified the NSE, while the status of any amended or revalidated in-principle approval remains unreported.